TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies

Neurobiology of Disease

Volumn 38, Issue 2, 2010, Pages 210-218

  Tanji, Kunikazu ^a   Kamitani, Tetsu ^b   Mori, Fumiaki ^a   Kakita, Akiyoshi ^c   Takahashi, Hitoshi ^c   Wakabayashi, Koichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

Synuclein; Dementia with Lewy bodies; Parkinson's disease; Tripartite motif protein 9 (TRIM9); Ubiquitin

Indexed keywords

TRIPARTITE MOTIF PROTEIN 9; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN STEM; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; EMBRYO; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT;

ALPHA-SYNUCLEIN; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRAIN; CARRIER PROTEINS; CELLS, CULTURED; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODY DISEASE; MICE; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE; UBIQUITIN-PROTEIN LIGASES;

EID: 77951208421     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.01.007     Document Type: Article

References (39)

1. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006, 351:602-611.
2. Balint I., Muller A., Nagy A., Kovacs G. Cloning and characterisation of the RBCC728/TRIM36 zinc-binding protein from the tumor suppressor gene region at chromosome 5q22.3. Gene 2004, 332:45-50.
3. Berti C., Messali S., Ballabio A., Reymond A., Meroni G. TRIM9 is specifically expressed in the embryonic and adult nervous system. Mech. Dev. 2002, 113:159-162.
4. Chen D., Gould C., Garza R., Gao T., Hampton R.Y., Newton A.C. Amplitude control of protein kinase C by RINCK, a novel E3 ubiquitin ligase. J. Biol. Chem. 2007, 282:33776-33787.
5. Chung K.K., Thomas B., Li X., Pletnikova O., Troncoso J.C., Marsh L., Dawson V.L., Dawson T.M. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 2004, 304:1328-1331.
6. Dhingra V., Li X., Liu Y., Fu Z.F. Proteomic profiling reveals that rabies virus infection results in differential expression of host proteins involved in ion homeostasis and synaptic physiology in the central nervous system. J. Neurovirol. 2007, 13:107-117.
7. Eldin P., Papon L., Oteiza A., Brocchi E., Lawson T.G., Mechti N. TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus. J. Gen. Virol. 2009, 90:536-545.
8. Freemont P.S. RING for destruction?. Curr. Biol. 2000, 10:R84-87.
9. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., Takeuchi O., Akira S., Chen Z., Inoue S., Jung J.U. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
10. Greenfield J.G., Graham D.I., Lantos P.L. Greenfield's neuropathology 2002, 196-271. Arnold, London.
11. Hampe C., Ardila-Osorio H., Fournier M., Brice A., Corti O. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity. Hum. Mol. Genet. 2006, 15:2059-2075.
12. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67:425-479.
13. Kallijarvi J., Lahtinen U., Hamalainen R., Lipsanen-Nyman M., Palvimo J.J., Lehesjoki A.E. TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase. Exp. Cell Res. 2005, 308:146-155.
14. Kim P.K., Hailey D.W., Mullen R.T., Lippincott-Schwartz J. Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:20567-20574.
15. Koegl M., Hoppe T., Schlenker S., Ulrich H.D., Mayer T.U., Jentsch S. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 1999, 96:635-644.
16. Kong H.J., Anderson D.E., Lee C.H., Jang M.K., Tamura T., Tailor P., Cho H.K., Cheong J., Xiong H., Morse H.C., Ozato K. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J. Immunol. 2007, 179:26-30.
17. Kramer M.L., Schulz-Schaeffer W.J. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J. Neurosci. 2007, 27:1405-1410.
18. Li Y., Chin L.S., Weigel C., Li L. Spring, a novel RING finger protein that regulates synaptic vesicle exocytosis. J. Biol. Chem. 2001, 276:40824-40833.
19. Lippa C.F., Fujiwara H., Mann D.M., Giasson B., Baba M., Schmidt M.L., Nee L.E., O'Connell B., Pollen D.A., St George-Hyslop P., Ghetti B., Nochlin D., Bird T.D., Cairns N.J., Lee V.M., Iwatsubo T., Trojanowski J.Q. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 1998, 153:1365-1370.
20. Matsuda N., Kitami T., Suzuki T., Mizuno Y., Hattori N., Tanaka K. Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro. J. Biol. Chem. 2006, 281:3204-3209.
21. Meng L., Mohan R., Kwok B.H., Elofsson M., Sin N., Crews C.M. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc. Natl. Acad. Sci. USA 1999, 96:10403-10408.
22. Miyajima N., Maruyama S., Nonomura K., Hatakeyama S. TRIM36 interacts with the kinetochore protein CENP-H and delays cell cycle progression. Biochem. Biophys. Res. Commun. 2009, 381:383-387.
23. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S., Pelicci P.G., Ballabio A. The tripartite motif family identifies cell compartments. EMBO J. 2001, 20:2140-2151.
24. Schlossmacher M.G., Frosch M.P., Gai W.P., Medina M., Sharma N., Forno L., Ochiishi T., Shimura H., Sharon R., Hattori N., Langston J.W., Mizuno Y., Hyman B.T., Selkoe D.J., Kosik K.S. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am. J. Pathol. 2002, 160:1655-1667.
25. Scott C.A., Rossiter J.P., Andrew R.D., Jackson A.C. Structural abnormalities in neurons are sufficient to explain the clinical disease and fatal outcome of experimental rabies in yellow fluorescent protein-expressing transgenic mice. J. Virol. 2008, 82:513-521.
26. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 2000, 25:302-305.
27. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
28. Squire L.R. Memory and Brain 1987, Oxford University Press, New York.
29. Sriram S.R., Li X., Ko H.S., Chung K.K., Wong E., Lim K.L., Dawson V.L., Dawson T.M. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin. Hum. Mol. Genet. 2005, 14:2571-2586.
30. Staropoli J.F., McDermott C., Martinat C., Schulman B., Demireva E., Abeliovich A. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 2003, 37:735-749.
31. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
32. Tanji K., Tanaka T., Mori F., Kito K., Takahashi H., Wakabayashi K., Kamitani T. NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am. J. Pathol. 2006, 169:553-565.
33. Vabulas R.M., Hartl F.U. Protein synthesis upon acute nutrient restriction relies on proteasome function. Science 2005, 310:1960-1963.
34. Wada K., Kamitani T. Autoantigen Ro52 is an E3 ubiquitin ligase. Biochem. Biophys. Res. Commun. 2006, 339:415-421.
35. Wakabayashi K., Engelender S., Yoshimoto M., Tsuji S., Ross C.A., Takahashi H. Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann. Neurol. 2000, 47:521-523.
36. Wakabayashi K., Yoshimoto M., Tsuji S., Takahashi H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett. 1998, 249:180-182.
37. Yamauchi K., Wada K., Tanji K., Tanaka M., Kamitani T. Ubiquitination of E3 ubiquitin ligase TRIM5 alpha and its potential role. FEBS J. 2008, 275:1540-1555.
38. Zhang H.X., Tanji K., Mori F., Wakabayashi K. Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43. Neurosci. Lett. 2008, 434:170-174.
39. Zuccato E., Blott E.J., Holt O., Sigismund S., Shaw M., Bossi G., Griffiths G.M. Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation. J. Cell. Sci. 2007, 120:191-199.